Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry

Introduction

The paper reviews the historical and contemporary relationship between psychiatry and psychedelic substances. It traces a long anthropological record of sacramental plant and fungal use to assist healing and memory access, notes a mid-twentieth-century revival of clinical interest (particularly with LSD and other hallucinogens), and then describes the subsequent collapse of mainstream research following widespread recreational uptake and regulatory prohibition. The author situates this history against a present-day resurgence of neuroscience-informed clinical and imaging studies that have re-opened interest in psychedelics' therapeutic mechanisms. Sessa sets out an argument that psychiatry and psychedelics need one another: psychiatry requires new therapeutic tools that reach the roots of trauma and treatment-resistant conditions, while psychedelics require medical validation, methodological rigour, and clinical integration to escape their marginalised, recreational-only status. The essay intends to chart the obstacles (cultural, political, methodological, and economic) that have impeded clinical progress and to propose a pragmatic path for reintroducing psychedelic-assisted approaches into mainstream psychiatric practice and training.